M. De Bruin

First name
M.
Middle name
L.
Last name
De Bruin
van Staa, T. P., Patel, D. ., Gallagher, A. M., & De Bruin, M. L. (2012). Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care data. Diabetologia. http://doi.org/10.1007/s00125-011-2390-3
Peeters, P. J., Bazelier, M. T., Uitdehaag, B. M., Leufkens, H. G., De Bruin, M. L., & de Vries, F. . (2014). The risk of venous thromboembolism in patients with multiple sclerosis: the Clinical Practice Research Datalink. J Thromb Haemost. http://doi.org/10.1111/jth.12523
Duijnhoven, R. G., Straus, S. M., Souverein, P. C., de Boer, A. ., Bosch, J. L., Hoes, A. W., & De Bruin, M. L. (2014). Long-term use of 5alpha-reductase inhibitors and the risk of male breast cancer. Cancer Causes Control. http://doi.org/10.1007/s10552-014-0455-6
Abbing-Karahagopian, V. ., Huerta, C. ., Souverein, P. C., de Abajo, F. ., Leufkens, H. G., Slattery, J. ., … De Bruin, M. L. (2014). Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications. Eur J Clin Pharmacol. http://doi.org/10.1007/s00228-014-1676-z
Peeters, P. J., Bazelier, M. T., Leufkens, H. G., de Vries, F. ., & De Bruin, M. L. (2015). The risk of colorectal cancer in patients with type 2 diabetes: associations with treatment stage and obesity. Diabetes Care. http://doi.org/10.2337/dc14-1175
Goossens, M. E., Zeegers, M. P., Bazelier, M. T., De Bruin, M. L., Buntinx, F. ., & de Vries, F. . (2015). Risk of bladder cancer in patients with diabetes: a retrospective cohort study. BMJ Open. http://doi.org/10.1136/bmjopen-2014-007470
Goossens, M. E., Buntinx, F. ., Zeegers, M. P., Driessen, J. H., De Bruin, M. L., & de Vries, F. . (2015). Influence of metformin intake on the risk of bladder cancer in type 2 diabetes patients. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.12740
Stolwijk, C. ., Essers, I. ., van Tubergen, A. ., Boonen, A. ., Bazelier, M. T., De Bruin, M. L., & de Vries, F. . (2015). The epidemiology of extra-articular manifestations in ankylosing spondylitis: a population-based matched cohort study. Ann Rheum Dis. http://doi.org/10.1136/annrheumdis-2014-205253
Knapen, L. M., van Dalem, J. ., Keulemans, Y. C., van Erp, N. P., Bazelier, M. T., De Bruin, M. L., … Driessen, J. H. (2016). Use of incretin agents and risk of pancreatic cancer: a population-based cohort study. Diabetes Obes Metab. http://doi.org/10.1111/dom.12605
Warnier, M. J., Rutten, F. H., Souverein, P. C., de Boer, A. ., Hoes, A. W., & De Bruin, M. L. (2015). Are ECG monitoring recommendations before prescription of QT-prolonging drugs applied in daily practice? The example of haloperidol. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.3792